4//SEC Filing
Finn Jonathan 4
Accession 0000950170-25-073522
CIK 0001488039other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:05 PM ET
Size
5.4 KB
Accession
0000950170-25-073522
Insider Transaction Report
Form 4
Finn Jonathan
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-15+125,000→ 125,000 totalExercise: $0.99Exp: 2035-05-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001981595
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:05 PM ET
- Size
- 5.4 KB